in

First in human trial of new drug raises hopes for patients with relapsed blood cancer

cancer

Credit: Unsplash/CC0 Public Domain

A new targeted drug, studied by researchers at The Ohio State University Comprehensive Cancer Center—Arthur G. James Cancer Hospital and Richard J. Solove Research Institute (OSUCCC—James), may offer a new treatment option for patients with blood cancers, including chronic lymphocytic leukemia (CLL) and…


Posted by Editor

Under Armour Taps Richfresh for Special NCAA Women’s Tracksuits

Under Armour Taps Richfresh for Special NCAA Women’s Tracksuits

Cruise confirms robotaxis rely on human assistance every four to five miles

Cruise confirms robotaxis rely on human assistance every four to five miles